{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:02:19Z","timestamp":1790416939608,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jaut.2012.11.002","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T11:34:33Z","timestamp":1354620873000},"page":"126-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"special_numbering":"C","title":["Autoimmune hepatitis: A comprehensive review"],"prefix":"10.1016","volume":"41","author":[{"given":"Rodrigo","family":"Liberal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte R.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2012.11.002_bib1","first-page":"113","article-title":"Blutprotein und Nahrungseiweiss","volume":"15","author":"Leber","year":"1950","journal-title":"Deutsch Gesellshaff Z Verdan Stoffwechselkr"},{"key":"10.1016\/j.jaut.2012.11.002_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(56)91483-0","article-title":"Lupoid hepatitis","volume":"271","author":"Mackay","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2012.11.002_bib3","first-page":"159","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2012.11.002_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hep.1840050309","article-title":"The immunologic diagnosis of chronic active \"autoimmune\" hepatitis: distinction from systemic lupus erythematosus","volume":"5","author":"Gurian","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00281-009-0170-7","article-title":"Autoimmune hepatitis","volume":"31","author":"Vergani","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jaut.2012.11.002_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0210-5705(03)70452-X","article-title":"Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain)","volume":"27","author":"Primo","year":"2004","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib13","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7861\/clinmedicine.7-2-119","article-title":"Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs","volume":"7","author":"Whalley","year":"2007","journal-title":"Clin Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib15","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2010.06384.x","article-title":"Population-based epidemiology study of autoimmune hepatitis: a disease of older women?","volume":"25","author":"Ngu","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0168-8278(97)80453-9","article-title":"Present status of autoimmune hepatitis in Japan\u2013correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis","volume":"26","author":"Toda","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0021-9681(80)90047-8","article-title":"Etiological spectrum of liver cirrhosis in the Chinese","volume":"33","author":"Lam","year":"1980","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.jaut.2012.11.002_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2010.06.032","article-title":"Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients","volume":"54","author":"Qiu","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2006.04.007","article-title":"Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre","volume":"45","author":"Al-Chalabi","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","article-title":"Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells","volume":"50","author":"Longhi","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib22","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","article-title":"HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis","volume":"45","author":"Djilali-Saiah","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","article-title":"A\u00a0functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis","volume":"69","author":"Agarwal","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaut.2012.11.002_bib26","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.jaut.2012.11.002_bib28","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","article-title":"Liver antigen-presenting cells","volume":"54","author":"Crispe","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.24508","article-title":"Cross-presentation of antigen by diverse subsets of murine liver cells","volume":"54","author":"Ebrahimkhani","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.autrev.2005.01.005","article-title":"T\u00a0cell immunity in autoimmune hepatitis","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaut.2012.11.002_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.1840120208","article-title":"Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease","volume":"12","author":"Lobo-Yeo","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jcp.44.2.107","article-title":"Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers","volume":"44","author":"Senaldi","year":"1991","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaut.2012.11.002_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood-2002-04-1164","article-title":"Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages","volume":"101","author":"Delneste","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2012.11.002_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jaut.2012.11.002_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.11.002_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM197807062990101","article-title":"Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis","volume":"299","author":"Jensen","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0168-8278(86)80026-5","article-title":"Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders","volume":"3","author":"McFarlane","year":"1986","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib39","doi-asserted-by":"crossref","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","article-title":"Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2012.11.002_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2009.03947.x","article-title":"Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis","volume":"157","author":"Harada","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2249.1992.tb06881.x","article-title":"Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease","volume":"89","author":"Wen","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A\u00a0multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib43","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1073\/pnas.75.3.1549","article-title":"Alteration in suppressor cell activity in chronic active hepatitis","volume":"75","author":"Hodgson","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2012.11.002_bib45","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM198211183072102","article-title":"Effect of corticosteroids on suppressor-cell activity in \"autoimmune\" and viral chronic active hepatitis","volume":"307","author":"Nouri-Aria","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(84)91691-X","article-title":"Antigen specific suppressor cell function in autoimmune chronic active hepatitis","volume":"1","author":"Vento","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2012.11.002_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaut.2012.11.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","author":"Peiseler","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2012.05.022","article-title":"Regulatory T cells in autoimmune hepatitis","author":"Longhi","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2012.04.005","article-title":"Regulatory T cells and autoimmune hepatitis: defective cells or a hostile environment?","author":"Oo","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ni.1817","article-title":"Mechanisms maintaining peripheral tolerance","volume":"11","author":"Mueller","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective Galectin-9\/Tim-3 pathway","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib54","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/hep.23536","article-title":"Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib55","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib56","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib57","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000199332","article-title":"'Acute' autoimmune hepatitis","volume":"34","author":"Crapper","year":"1986","journal-title":"Digestion"},{"key":"10.1016\/j.jaut.2012.11.002_bib60","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib63","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","author":"Czaja","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib64","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib65","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1572-0241.2006.00479.x","article-title":"Pregnancy in autoimmune hepatitis: outcome and risk factors","volume":"101","author":"Schramm","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","article-title":"Management and outcome of pregnancy in autoimmune hepatitis","volume":"48","author":"Heneghan","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2012.11.002_bib67","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/00365520802130183","article-title":"Epidemiology and the initial presentation of autoimmune hepatitis in Sweden: a nationwide study","volume":"43","author":"Werner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib68","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib70","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jcla.20047","article-title":"High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies","volume":"19","author":"Villalta","year":"2005","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.jaut.2012.11.002_bib71","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/kem158","article-title":"The abdominal manifestations of the antiphospholipid syndrome","volume":"46","author":"Uthman","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaut.2012.11.002_bib72","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1572-0241.2000.02346.x","article-title":"Autoimmune pancreatitis and hepatitis: an uncommon association","volume":"95","author":"Quinet de Andrade","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2169\/internalmedicine.44.335","article-title":"Felty's syndrome with chronic hepatitis and compatible autoimmune hepatitis: a case presentation","volume":"44","author":"Sema","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib74","first-page":"928","article-title":"Fibrosing alveolitis in a 7-year-old girl with autoimmune hemolytic anemia and autoimmune hepatitis","volume":"45","author":"Paul","year":"1991","journal-title":"Pneumologie"},{"key":"10.1016\/j.jaut.2012.11.002_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2169\/internalmedicine.41.72","article-title":"Autoimmune hepatitis accompanied by idiopathic thrombocytopenic purpura and Sjogren's syndrome","volume":"41","author":"Yamaike","year":"2002","journal-title":"Intern Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib76","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.3748\/wjg.v12.i33.5396","article-title":"Multiplex neuritis in a patient with autoimmune hepatitis: a case report","volume":"12","author":"Luth","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3904\/kjim.2000.15.2.151","article-title":"Autoimmune hepatitis in a patient with myasthenia gravis and thymoma\u2013a report on the first case in Korea","volume":"15","author":"Han","year":"2000","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib78","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/gut.30.7.1018","article-title":"Active chronic hepatitis and febrile panniculitis","volume":"30","author":"Banerjee","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2012.11.002_bib79","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/pgmj.70.820.128","article-title":"Chronic active hepatitis in the type I polyglandular autoimmune syndrome","volume":"70","author":"Michele","year":"1994","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jaut.2012.11.002_bib80","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jnnp.59.5.558","article-title":"Autoimmune chronic active hepatitis and polymyositis in a patient with myasthenia gravis and thymoma","volume":"59","author":"Ko","year":"1995","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaut.2012.11.002_bib81","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3748\/wjg.v12.i10.1637","article-title":"Uveitis in autoimmune hepatitis: a case report","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib82","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0168-8278(90)90148-K","article-title":"Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies","volume":"10","author":"Sacher","year":"1990","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib83","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib84","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group","volume":"41","author":"Vergani","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib85","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1023\/A:1018809431189","article-title":"Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis","volume":"42","author":"Czaja","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2012.11.002_bib86","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \"healthy\" individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaut.2012.11.002_bib87","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/000992280404300709","article-title":"Frequency of antinuclear antibodies in healthy children and adolescents","volume":"43","author":"Hilario","year":"2004","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaut.2012.11.002_bib88","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.3748\/wjg.14.3374","article-title":"Autoimmune liver serology: current diagnostic and clinical challenges","volume":"14","author":"Bogdanos","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib89","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaut.2012.11.002_bib90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/0891693021000054066","article-title":"Smooth muscle antibodies and type 1 autoimmune hepatitis","volume":"35","author":"Muratori","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaut.2012.11.002_bib91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2002-35704","article-title":"Autoantibodies and autoantigens in autoimmune hepatitis","volume":"22","author":"Strassburg","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2012.11.002_bib92","first-page":"331","article-title":"Microsomal antibodies in active chronic hepatitis and other disorders","volume":"15","author":"Rizzetto","year":"1973","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib93","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib94","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib95","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2012.11.002_bib96","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib97","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib98","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2012.11.002_bib99","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2012.11.002_bib100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib101","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaut.2012.11.002_bib102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.1173755","article-title":"The human SepSecS-tRNASec complex reveals the mechanism of selenocysteine formation","volume":"325","author":"Palioura","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jaut.2012.11.002_bib103","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/hep.510260229","article-title":"Histological findings in chronic hepatitis C with autoimmune features","volume":"26","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib104","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hep.24080","article-title":"Autoimmune acute liver failure: proposed clinical and histological criteria","volume":"53","author":"Stravitz","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","article-title":"Validation of scoring system for diagnosis of autoimmune hepatitis","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2012.11.002_bib107","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib108","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/hep.22825","article-title":"Validation of simplified diagnostic criteria for autoimmune hepatitis in Italian patients","volume":"49","author":"Muratori","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib109","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","article-title":"The variant forms of autoimmune hepatitis","volume":"125","author":"Czaja","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib111","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jaut.2012.11.002_bib112","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib113","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.1840360615","article-title":"Evolution of autoimmune hepatitis to primary sclerosing cholangitis: a sequential syndrome","volume":"36","author":"Abdo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1089-3261(03)00132-6","article-title":"Primary biliary cirrhosis and autoimmune cholangiopathy","volume":"8","author":"Vierling","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jaut.2012.11.002_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00432159","article-title":"Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity","volume":"373","author":"Kloppel","year":"1977","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.jaut.2012.11.002_bib116","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.21229","article-title":"Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis","volume":"44","author":"Poupon","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib118","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib120","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0016-5085(87)91082-1","article-title":"Primary sclerosing cholangitis in childhood","volume":"92","author":"el-Shabrawi","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib121","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib122","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib123","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib124","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib125","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1517\/14656566.2011.524206","article-title":"Pharmacological management of autoimmune hepatitis","volume":"12","author":"Vergani","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaut.2012.11.002_bib126","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib127","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3748\/wjg.14.3301","article-title":"Clinical features and management of autoimmune hepatitis","volume":"14","author":"Krawitt","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib128","first-page":"351","article-title":"Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis","volume":"23","author":"Ben Ari","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/gut.52.1.140","article-title":"Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine","volume":"52","author":"Kaskas","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2012.11.002_bib130","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaut.2012.11.002_bib131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840100110","article-title":"Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis","volume":"10","author":"Wang","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib132","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib133","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib134","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib135","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib136","first-page":"571","article-title":"Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis\u2013report of three cases","volume":"35","author":"Kanzler","year":"1997","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib137","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib138","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000322693","article-title":"A\u00a0case of autoimmune hepatitis treated with rituximab","volume":"4","author":"Barth","year":"2010","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib139","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1038\/ajg.2009.433","article-title":"A\u00a0case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade","volume":"104","author":"Weiler-Normann","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib140","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","article-title":"Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis","volume":"64","author":"Germano","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaut.2012.11.002_bib141","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2012.11.002_bib142","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaut.2012.11.002_bib143","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.2004.30457.x","article-title":"Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy","volume":"99","author":"Verma","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib144","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3748\/wjg.14.3388","article-title":"Transplantation in autoimmune liver diseases","volume":"14","author":"Mottershead","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaut.2012.11.002_bib145","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","author":"Liberal","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaut.2012.11.002_bib146","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2012.11.002_bib147","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib148","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.168.2.801","article-title":"Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily","volume":"168","author":"Gueguen","year":"1988","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaut.2012.11.002_bib149","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21658","article-title":"Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2","volume":"46","author":"Longhi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2012.11.002_bib150","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841112001333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841112001333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:06:11Z","timestamp":1760256371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841112001333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":150,"alternative-id":["S0896841112001333"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2012.11.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune hepatitis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2012.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}